## **Core Concept**
The question tests understanding of immunosuppressive drugs, specifically those that inhibit the formation of Interleukin-2 (IL-2), a crucial cytokine involved in T-cell activation and proliferation. IL-2 is essential for the growth, proliferation, and survival of T cells. Drugs that inhibit IL-2 formation are primarily used to prevent transplant rejection and treat autoimmune diseases.

## **Why the Correct Answer is Right**
Cyclosporine and Tacrolimus are well-known immunosuppressive agents that inhibit the formation of IL-2. They do so by forming complexes with cyclophilin and FK-binding protein, respectively, which then inhibit calcineurin. Calcineurin is a phosphatase necessary for the activation of Nuclear Factor of Activated T-cells (NFAT), a transcription factor required for the expression of the IL-2 gene. By inhibiting calcineurin, these drugs effectively reduce IL-2 production, thereby suppressing T-cell activation and proliferation.

## **Why Each Wrong Option is Incorrect**
- **Option A: Cycloserine** - Cycloserine is an antibiotic used in the treatment of tuberculosis. It works by inhibiting cell wall synthesis in bacteria and does not have a significant impact on IL-2 formation.
- **Option C: OKT-3** - OKT-3, also known as Muromonab-CD3, is a monoclonal antibody that targets the CD3 receptor on T cells. While it does suppress T-cell function, it does so by modulating T-cell receptor signaling rather than specifically inhibiting IL-2 formation.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Cyclosporine** and **Tacrolimus** are cornerstone immunosuppressive drugs used to prevent organ rejection in transplant patients. They are specifically known for their ability to inhibit calcineurin, which leads to decreased production of IL-2 and subsequent immunosuppression. This mechanism is critical for their therapeutic effects but also underlies their potential side effects, such as nephrotoxicity.

## **Correct Answer:** B. Cyclosporine, D. Tacrolimus.